Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Renshen Yangrong Granule vs Decoction Pieces in Qi Deficiency Syndrome
ChiCTR-IPR-17011555Phase 4Recruiting
- Sponsor
- Hubei Provincial Traditional Chinese Medical Hospital
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of modified renshen yangrong in Qi deficiency (2 arms), sponsored by Hubei Provincial Traditional Chinese Medical Hospital. Primary endpoints: clinical efficacy, fatigue scale score and 6 more. Started Jun 2017; status: recruiting.
02
Drugs
modified renshen yangrong
03
Conditions
Qi deficiency
Beyond the preview
Go deeper on ChiCTR-IPR-17011555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011555.